Trials / Conditions / Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms (LUTS)

16 registered clinical trials studyying Lower Urinary Tract Symptoms (LUTS) — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer NCT07526675	Benha University	N/A
Recruiting	Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults NCT07485205	Bright Uro	N/A
Not Yet Recruiting	Predictors of Trifecta Achievement After HoLEP NCT07429994	Ondokuz Mayıs University	N/A
Recruiting	Genital Hygiene, Toilet Behaviors, and LUTS in Normal Weight and Obese Women NCT07383987	Gulhane School of Medicine	—
Recruiting	RCT on Running Water Sound During Urodynamic NCT07451548	Princess Margaret Hospital, Hong Kong	N/A
Not Yet Recruiting	Uroflowmetry Curve Types and IPSS in Men With LUTS NCT07016776	Tarik Emre Sener	—
Enrolling By Invitation	Study of Transition in Real-life Experiences Affecting Micturition and Well-being in Adolescent Years NCT07339865	University Hospital, Ghent	—
Recruiting	Reducing Disparities in Urinary Control Symptoms for Minority Women NCT06798311	University of Chicago	N/A
Active Not Recruiting	Butterfly Pivotal Study NCT05341661	Butterfly Medical Ltd.	N/A
Active Not Recruiting	Safety and Effectiveness Study of the Zenflow Spring System NCT04987138	Zenflow, Inc.	N/A
Unknown	Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia NCT02592473	University of Virginia	N/A
Completed	Benign Prostatic Hyperplasia and Ischemic Heart DIsease NCT03856242	I.M. Sechenov First Moscow State Medical University	Phase 4
Completed	Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-002 NCT01846793	Nymox Corporation	Phase 3
Completed	Vesitirim™ in Men Postmarketing Observational Study NCT01639794	Astellas Pharma Europe Ltd.	—
Completed	A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperpla NCT00947882	Ferring Pharmaceuticals	Phase 2
Terminated	Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH) NCT00743184	Spectrum Pharmaceuticals, Inc	Phase 2